In Vivo Transcriptome of Lactobacillus acidophilus and Colonization Impact on Murine Host Intestinal Gene Expression
- 2021-02-23
- mBio 12(1)
- Y. Goh
- R. Barrangou
- T. Klaenhammer
- PubMed: 33500337
- DOI: 10.1128/mBio.03399-20
Abstract
Lactobacillus acidophilus NCFM is a probiotic strain commonly used in dairy products and dietary supplements. Postgenome in vitro studies of NCFM thus far have linked potential key genotypes to its probiotic-relevant attributes, including gut survival, prebiotic utilization, host interactions, and immunomodulatory activities. To corroborate and extend beyond previous in vivo and in vitro functional studies, we employed a dual RNA sequencing (RNA-seq) transcriptomic approach to identify genes potentially driving the gut fitness and activities of L. acidophilus NCFM in vivo, and in parallel, examine the ileal transcriptional response of its murine hosts during monocolonization. Spatial expression profiling of NCFM from the ileum through the colon revealed a set of 134 core genes that were consistently overexpressed during gut transit. These in vivo core genes are predominantly involved in the metabolism of carbohydrates, amino acids, and nucleotides, along with mucus-binding proteins and adhesion factors, confirming their functionally important roles in nutrient acquisition and gut retention. Functional characterization of the highly expressed major S-layer-encoding gene established its indispensable role as a cell shape determinant and maintenance of cell surface integrity, essential for viability and probiotic attributes. Host colonization by L. acidophilus resulted in significant downregulation of several proinflammatory cytokines and tight junction proteins. Genes related to redox signaling, mucin glycosylation, and circadian rhythm modulation were induced, suggesting impacts on intestinal development and immune functions. Metagenomic analysis of NCFM populations postcolonization demonstrated the genomic stability of L. acidophilus as a gut transient and further established its safety as a probiotic and biotherapeutic delivery platform.IMPORTANCE To date, our basis for comprehending the probiotic mechanisms of Lactobacillus acidophilus, one of the most widely consumed probiotic microbes, was largely limited to in vitro functional genomic studies. Using a germfree murine colonization model, in vivo-based transcriptional studies provided the first view of how L. acidophilus survives in the mammalian gut environment, including gene expression patterns linked to survival, efficient nutrient acquisition, stress adaptation, and host interactions. Examination of the host ileal transcriptional response, the primary effector site of L. acidophilus, has also shed light into the mechanistic roles of this probiotic microbe in promoting anti-inflammatory responses, maintaining intestinal epithelial homeostasis and modulation of the circadian-metabolic axis in its host.
Keywords: Lactobacillus; acidophilus; gut adaptation; in vivo gene expression; mouse colonization; probiotic.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Lactobacillus acidophilus | Adjusted Immune Function | Beneficial | Moderate |
Lactobacillus acidophilus | Enhanced Intestinal Development | Beneficial | Moderate |
Lactobacillus acidophilus | Maintained Intestinal Epithelial Homeostasis | Beneficial | Moderate |
Lactobacillus acidophilus | Reduced Pro-inflammatory Cytokine Levels | Beneficial | Moderate |
Lactobacillus acidophilus | Regulated Circadian-Metabolic Axis | Beneficial | Moderate |
Lactobacillus acidophilus HA-122 | Improved Circadian-Metabolic Function | Beneficial | Small |
Lactobacillus acidophilus HA-122 | Maintained Intestinal Epithelial Homeostasis | Beneficial | Moderate |
Lactobacillus acidophilus HA-122 | Reduced Pro-Inflammatory Cytokines | Beneficial | Moderate |
Lactobacillus acidophilus MAK32L61A | Enhanced Intestinal Development | Beneficial | Moderate |
Lactobacillus acidophilus MAK32L61A | Maintained Intestinal Epithelial Homeostasis | Beneficial | Moderate |
Lactobacillus acidophilus MAK32L61A | Reduced Inflammation Levels | Beneficial | Moderate |
Lactobacillus acidophilus NCFM | Enhanced Immune Function | Beneficial | Moderate |
Lactobacillus acidophilus NCFM | Enhanced Intestinal Development | Beneficial | Moderate |
Lactobacillus acidophilus NCFM | Improved Gut Homeostasis | Beneficial | Moderate |
Lactobacillus acidophilus NCFM | Reduced Inflammation Levels | Beneficial | Moderate |
Lactobacillus acidophilus NCIMB 30333 | Improved Circadian-Metabolic Function | Beneficial | Small |
Lactobacillus acidophilus NCIMB 30333 | Maintained Intestinal Epithelial Homeostasis | Beneficial | Moderate |
Lactobacillus acidophilus NCIMB 30333 | Reduced Pro-Inflammatory Cytokines | Beneficial | Moderate |
Lactobacillus acidophilus R0418 | Enhanced Circadian Rhythm Gene Expression | Beneficial | Moderate |
Lactobacillus acidophilus R0418 | Enhanced Redox Signaling Gene Expression | Beneficial | Moderate |
Lactobacillus acidophilus R0418 | Increased Expression of Genes Related to Mucin Glycosylation | Beneficial | Moderate |
Lactobacillus acidophilus R0418 | Reduced Pro-inflammatory Cytokine Levels | Beneficial | Moderate |
Lactobacillus acidophilus UALa01 | Improved Circadian-Metabolic Function | Beneficial | Small |
Lactobacillus acidophilus UALa01 | Maintained Intestinal Epithelial Homeostasis | Beneficial | Moderate |
Lactobacillus acidophilus UALa01 | Reduced Inflammatory Response | Beneficial | Moderate |